Subject(s)

Angina Pectoris , Adrenergic beta-Antagonists/administration & dosage , Adrenergic beta-Antagonists/therapeutic use , Adult , Age Factors , Aged , Aged, 80 and over , Angina Pectoris/diagnosis , Angina Pectoris/drug therapy , Angina Pectoris/epidemiology , Angiotensin-Converting Enzyme Inhibitors/administration & dosage , Angiotensin-Converting Enzyme Inhibitors/therapeutic use , Aspirin/administration & dosage , Aspirin/therapeutic use , Atenolol/administration & dosage , Atenolol/therapeutic use , Body Mass Index , Calcium Channel Blockers/administration & dosage , Calcium Channel Blockers/therapeutic use , Diabetes Complications , Drug Therapy, Combination , Electrocardiography , Female , Fibrinolytic Agents/administration & dosage , Fibrinolytic Agents/therapeutic use , Humans , Hyperlipidemias/complications , Hyperlipidemias/drug therapy , Male , Middle Aged , Platelet Aggregation Inhibitors/administration & dosage , Platelet Aggregation Inhibitors/therapeutic use , Risk Factors , Russia/epidemiology , Sex Factors , Smoking/adverse effects , Time Factors , Vasodilator Agents/administration & dosage , Vasodilator Agents/therapeutic use , Verapamil/administration & dosage , Verapamil/therapeutic use